We previously embarked on a groundbreaking journey, supporting the launch of the most significant orphan drug of the year. Our mission was particularly challenging as we ventured into the intricate field of pediatric neurology, specifically addressing seizures with the first cannabidiol-derived medicine. This project not only pushed the boundaries of medical innovation, but also underscored our unwavering commitment to making a meaningful impact on patients' lives.
Recently, Integritas encountered another remarkable opportunity to assist a different firm with the launch of their rare, yet equally critical, eye disease treatment. These dual endeavors showcased our exceptional versatility and expertise, spanning diverse therapeutic areas, and our ability to thrive in complex and evolving landscapes.
Our approaches transcended conventional strategies. We harnessed the power of our cutting-edge Proprietary Hybrid Segmentation/Targeting Model, utilizing Advanced Analytics with MaxDiff/TURF message testing to uncover invaluable insights. We introduced the industry to FastTracker, our proprietary 'real-time' launch feedback system, providing our clients with unparalleled real-time visibility into market dynamics.
In the context of the pediatric neurology launch, where every detail mattered, we implemented custom-designed, multi-modal healthcare provider (HCP) recruitment strategies. This meticulous approach ensured that these difficult to recruit professionals were engaged at the right time, setting the stage for their participation and success.
The year 2020 brought a seismic shift to the global landscape with the onset of the COVID-19 pandemic. Traditional office-based detailing, the cornerstone of pharmaceutical marketing, was severely restricted. However, we saw this as an opportunity for innovation. Our near real-time FastTracker proved to be a game-changer, enabling our client to swiftly and successfully transition from in-person interactions to virtual engagements.
Our analytics and market research provided critical insights, highlighting barriers to product use. This information not only supported the development of new patient messages but also guided our client's shift from physician marketing to patient demand generation.
This project was a testament to our unwavering commitment to excellence, our ability to navigate uncharted territory, and our capacity to thrive in the face of unexpected challenges. Integritas proved once again that we can handle the rare and the unexpected, all while delivering exceptional results!